Bradford D, Larkins E, Mushti SL, Rodriguez L, et al. FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid cancers with RET Gene Mutations or Fusions. Clin Cancer Res 2020 Nov 25. pii: 1078-0432.CCR-20-3558.
PMID: 33239432